Ethicon Gynecare Archives - Carey Danis & Lowe

CA & WA Attorneys General Sue J&J

By | Transvaginal Mesh, Uncategorized

transvaginal mesh lawsuitThe Attorney General of California and Washington state filed separate transvaginal mesh lawsuits targeting Ethicon and Johnson & Johnson (J&J). Their lawsuits claim that the pharmaceutical giant knew of the serious risks associated with their vaginal mesh products, but the company hid this knowledge. By doing so, Ethicon and J&J violated consumer safety, according to the lawsuits.

Lawsuits Pending in Federal Court

These lawsuits come as thousands of similar cases remain pending in a federal court in West Virginia. Ethicon and J&J are defendants in a multidistrict litigation (MDL) in the US District Court for the Southern District of West Virginia. The MDL is In re: Ethicon, Inc., Pelvic Repair System Products Liability Litigation, MDL no. 2327.

As of late June 2016, there are over 32,000 transvaginal mesh lawsuits pending in the Ethicon MDL.

J&J Responds to Lawsuits

J&J reacted to the actions of these two Attorneys General by issuing a statement emphasizing that neither they nor their subsidiary, Ethicon, committed any wrongdoing in developing, manufacturing, and marketing their pelvic slings.

The company plans to defend itself against these claims.

Do you have a pelvic sling case?

You can discuss your case with one of our experienced attorneys. We offer free, no obligation case evaluations. Call 800.721.2519, or complete our confidential online form.

J&J and Ethicon to Pay Penalty for Document Mishandling

By | Defective Medical Device litigation, Transvaginal Mesh, Uncategorized

Boston Scientific Ordered to Release Defective Transvaginal Mesh DocumentsBoston Scientific Ordered to Release Defective Transvaginal Mesh DocumentsJohnson & Johnson and Ethicon mishandled internal documents that were of great importance in the Ethicon multidistrict litigation (MDL) being heard in West Virginia. As a result, U.S. Magistrate Judge Cheryl Eifert penalized Johnson & Johnson, and their subsidiary, Ethicon, by ordering them to pay a fine.

The court is still deciding on the penalty amount.

It is unclear if Johnson & Johnson and Ethicon, the medical device manufacturer behind the Gynecare Prolift transvaginal mesh product, purposefully destroyed the internal documents in question. Since purposeful destruction was never proven, Johnson & Johnson and Ethicon were not dealt more severe penalties.

There are over 16,000 transvaginal mesh lawsuits pending in the Ethicon MDL in West Virginia. The Ethicon MDL is In re: Ethicon, Inc. Pelvic Repair Systems Product Liability Litigation MDL no. 2327, and is being heard in the U.S. District Court for the Southern District of West Virginia.

Victims of transvaginal mesh, including those who received an implant of the Ethicon Gynecare Prolift, have contacted Carey Danis & Lowe for legal assistance. The team of class action attorneys at Carey Danis & Lowe currently represents many women across the United States in transvaginal mesh lawsuits.

Explore your legal options and eligibility for compensation with Carey Danis & Lowe today. Schedule an appointment to meet with one of our attorneys in person at one of our four locations. We have law offices in Missouri, Illinois, and Florida.

Our attorneys are also available to discuss your case over the phone. Contact our law offices by calling 800.721.2519.

You can also contact us by completing a personal injury claim form.

Transvaginal Mesh Lawsuit News: New Case Management Order Filed in Gynecare Transvaginal Mesh Litigation in New Jersey

By | Defective Medical Device litigation, Transvaginal Mesh, Uncategorized

ethicon johson johnsonA new case management order was recently filed in the transvaginal mesh multicountry litigation (MCL) in the Superior Court of New Jersey in Atlantic County. Filed on June 26, 2013, the case management order covers transvaginal mesh lawsuit issues, including the scheduling of defendants’ witness depositions and delivery of transvaginal mesh product data from the defendants’ records to the plaintiffs.

According to Carey Danis & Lowe transvaginal mesh lawyers, from the latest case management order, it is clear that a considerable amount of headway has been made into the Ethicon Gynecare transvaginal mesh MCL in New Jersey. As a law firm that represents individuals who claim to have been injured by transvaginal mesh, Carey Danis & Lowe is encouraged by this progress, as it is a clear indicator of a more efficient and expedited process for plaintiffs whose transvaginal mesh lawsuits were consolidated into the MCL.

Plaintiffs have filed transvaginal mesh lawsuits claiming serious health complications following transvaginal mesh implantation. The most commonly reported issues are transvaginal mesh erosion and contraction, infection, pelvic area pain, bleeding, and pain during intercourse. In addition, plaintiffs have also reported that, in order to remove the defective transvaginal mesh, they had to undergo numerous surgeries.

There are currently 3,408 transvaginal mesh lawsuits in the Gynecare MCL in New Jersey, as of July 6, 2013. The case is In re: Pelvic Mesh / Gynecare Litigation case no. 291 CT, and is being presided over by Judge Carol E. Higbee.

If you or someone you love has been injured by transvaginal mesh, such as Ethicon’s Gynecare transvaginal mesh products, contact the experienced transvaginal mesh lawyers at Carey Danis & Lowe. In addition to a free legal evaluation, our transvaginal mesh lawyers can also provide assistance with filing a transvaginal mesh lawsuit.

Contact Carey Danis & Lowe today by calling 800.721.2519 or by submitting a personal injury claim form.

Transvaginal Mesh Safety Information Disclosure & Transvaginal Mesh MDL Grows Larger

By | Defective Medical Device litigation, Transvaginal Mesh, Uncategorized

Published September 11, 2012 on Carey & Danis

Transvaginal Mesh Safety Information Disclosure & Transvaginal Mesh MDL Grows LargerA manufacturer of transvaginal mesh products has recently been ordered in a vaginal mesh federal lawsuit to fully supply the safety information it imparted to the U.S. Food and Drug Administration (FDA) for the purpose of gathering whether the medical device manufacturer withheld any integral pieces of data regarding negative impacts on health from use of its transvaginal mesh product.

A superior court judge in New Jersey made the request of the transvaginal mesh manufacturer, Ethicon Inc., that it release documents on the subject of its clinical trial data and safety observations of its Gynecare transvaginal mesh products. In a report by Bloomberg news, it is understood that the FDA in 2007 mandated that, as adequate safety information was never recorded in regards to Ethicon’s Gynecare transvaginal mesh products, the medical device manufacturer remove such products from the market.

According to the Bloomberg report, Ethicon continued to sell its Gynecare transvaginal mesh products to patients in spite of the FDA mandate. Apparently, the total dismissal of such an FDA mandate is considered a violation of the Federal Food, Drug, and Cosmetic Act. Ethicon reported that, without receiving official FDA approval, they could market and sell the Gynecare transvaginal mesh products because they had received prior FDA approval on a similar transvaginal mesh product. The release of the Gynecare transvaginal mesh line has been referred to as a fast tracking process, one that eliminates the important safety checks via the FDA.

In a multidistrict litigation (MDL), presided over by Judge Joseph R. Goodwin in the U.S. District Court for the Southern Court of Virginia, it has been reported by a Drugwatch journalist that two Arkansas residents have filed a transvaginal mesh lawsuit against medical device manufacturer Boston Scientific Center. The Arkansas couple’s lawsuit makes the claim that Boston Scientific Center developed a transvaginal mesh product made out of materials that cause painful internal tissue inflammation.

Boston Scientific Center’s transvaginal mesh product under question is made out of a monofilament polypropylene that, according to the plaintiff, was known by the manufacturer to cause tissue damage. However, despite such knowledge, the medical device manufacturer made the decision to dismiss such important safety information in order to place the transvaginal mesh product on the market. In the plaintiff’s words, she has suffered enormously from receiving an implantation of Boston Scientific Center’s transvaginal mesh.

Transvaginal mesh is a medical device used as a reinforcing structure, and is especially useful in cases where a patient’s vaginal wall tissues can no longer support surrounding organs. In theory, the surgical implantation of transvaginal mesh should alter a patient’s life for the better, but such is often not the case due to medical device manufacturers releasing products onto the market that are understood to cause severe harm when surgically implanted.

Four Vaginal Mesh Lawsuit MDLs Receive Co-Lead Counsel

By | Defective Medical Device litigation, Transvaginal Mesh, Uncategorized

Published May 10, 2012 on InjuryLawyer

The U.S. Judicial Panel on Multidistrict Litigation has aggregated transvaginal mesh lawsuits from across the country into four multidistrict litigations (MDLs), relating to four separate named defendants. The lawsuits all relate to allegations of mesh complications.

Transvaginal mesh is surgically implanted in a patient for the purpose of treating stress urinary incontinence and pelvic organ prolapse (POP).  The device has been connected with a host of vaginal mesh complications, many serious and requiring surgical interventions.

MDL plaintiffs allege transvaginal mesh complications

The four named defendants in the separate MDLs are American Medical Systems, Boston Scientific, C.R. Bard and Ethicon/Gynecare, which each manufacture a vaginal mesh model. The consolidation of individual lawsuits into an MDL is meant to streamline the judicial process for cases making similar claims.

All cases involved in the side effects MDLs make claims that the mesh manufacturers did not conduct sufficient research regarding possible mesh complications. As a result, consumers allegedly were insufficiently warned about the possibility of chronic infections, mesh erosions, and incontinence from vaginal mesh.

Transvaginal mesh lawyer appointed co-lead counsel

In organizing the MDLs, three attorneys have been chosen as coordinating co-lead counsel with the assigned responsibility to manage and delegate individual tasks within the MDL. These responsibilities include evaluating other lawyers for possible positions common to all four MDLs.

Each individual MDL has been assigned two attorneys as co-lead counsel.  These lawyers will handle the particularities of the individual MDLs, as well as speak on behalf of all plaintiffs during pretrial proceedings.

A steering committee of over 60 attorneys has been selected to divide pretrial duties and coordinate discovery across all four lawsuit MDLs.

Bolstering the claims of existing MDL plaintiffs, in July of 2011 the FDA issued a safety warning that it had been unable to find evidence that vaginal mesh was better able to treat women than other methods with fewer risks for complications.  As the MDL progresses, a steadily increasing number of plaintiffs are signing on to seek justice for their injuries.